Press Releases

WASHINGTON, April 3 – Sen. Bernie Sanders (I-Vt.) and Rep. Pramila Jayapal (D-Wash.) introduced legislation Monday to make public colleges and universities tuition-free for working families and to significantly reduce student debt. “Higher education in America should be a right for all, not a privilege for the few,” Sanders said. “If we are to succeed in a highly competitive global

WASHINGTON, March 28 – Faulting an “unprecedented break with past practice,” Sen. Bernie Sanders, the Senate Budget Committee ranking member, on Tuesday called on the panel’s chairman to schedule public hearings on President Donald Trump’s “morally obscene” budget blueprint. Sanders said the president’s proposal “includes unacceptably painful cuts to programs that senior citizens, children, persons with disabilities and working people

BURLINGTON, Vt., March 24 – U.S. Sen. Bernie Sanders (I-Vt.) released the following statement Friday after House Republican leaders pulled legislation to repeal the Affordable Care Act from consideration on the House floor: “The defeat of the disastrous Trump-Ryan health care bill is a major victory for the working families of this country and for the hundreds of thousands who attended

WASHINGTON, March 23 – Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday on the nomination of U.S. Court of Appeals Judge Neil Gorsuch to be an associate justice of the United States Supreme Court: “Americans deserve a Supreme Court justice who respects the rights of workers to be treated fairly instead of bowing to big business. We cannot stand

WASHINGTON, March 22 – At a rally Wednesday outside the U.S. Capitol, Sen. Bernie Sanders (I-Vt.) called for the defeat of the Wall Street lawyer whom President Donald Trump wants to regulate Wall Street. “We need somebody who is prepared to confront the system, not someone who is part of the system,” Sanders said of former Goldman Sachs counsel Jay

WASHINGTON, March 22 –  Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.), Ranking Member of the House Committee on Oversight and Government Reform, requested information Wednesday from PTC Therapeutics, Inc. about the price they intend to charge for the brand name version of deflazacourt, a drug used to treat a deadly genetic muscle deterioration disorder. PTC recently purchased